ALXN - Alexion Pharmaceuticals: Progress Being Made Challenges Remain
Alexion Pharmaceuticals (ALXN) is a name which surfaced on my radar last year as I was looking across the biotechnology sector for bargains. Unfortunately, Alexion did not present real value in my eyes although I noted that appeal was on the increase.
Shares traded at $115 at the time and today they trade roughly $10 higher, with shares having ranged between $90 and $140 per share over the past twelve months. Early 2018 I noted that growth and lagging share price made that appeal was on the increase, yet my caution was based